NEXGEL, Inc. (NXGL)

USD 4.23

(-10.19%)

Market Cap (In USD)

28.72 Million

Revenue (In USD)

4.08 Million

Net Income (In USD)

-3.15 Million

Avg. Volume

50.89 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.84-5.1
PE
-
EPS
-
Beta Value
0.731
ISIN
US65344E1073
CUSIP
65344E107
CIK
1468929
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Adam R. Levy
Employee Count
-
Website
https://nexgel.com
Ipo Date
2021-12-22
Details
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.